Surgery, chemotherapy, and/or radiation therapy are routinely used to treat Wilms tumor (a kidney cancer that most commonly occurs in children). However, some treatments can cause side effects later in life. Doctors are therefore seeking effective treatment regimens that have a lower risk of late effects.
In this Children’s Oncology Group study, researchers are determining the best way to treat patients with different types of higher-risk Wilms tumors which had a favorable histology at the time of diagnosis. The goals of the study are to find out:
To be eligible for this study, patients must meet several criteria, including but not limited to the following:
For more information about this study and to inquire about eligibility, please contact Dr. Rachel Kobos at 212-639-8451.